15. A major advantage of the hybrid closed-loop system is that it
Answer: B
The hybrid closed-loop system provides automated monitoring and insulin dosing with minimal input from the patient.
The hybrid closed-loop system, also known as the artificial pancreas, simplifies diabetes management by automating the process of monitoring blood glucose levels and adjusting insulin delivery, requiring less active involvement from the patient.
A) keeps the patient disciplined about diet and treatment.
While discipline in diet and treatment is important for managing type 1 diabetes, the hybrid closed-loop system does not primarily focus on enforcing discipline. Instead, it automates insulin delivery and monitoring, which reduces the burden on patients and allows them more freedom in their daily lives.
B) provides automated monitoring and insulin dosing with minimal input from the patient.
This option accurately describes the key advantage of the hybrid closed-loop system. It combines glucose monitoring and insulin delivery into one automated system, allowing patients to have their insulin needs managed with less manual intervention, thus greatly enhancing convenience and quality of life.
C) eliminates the need for consistent treatment.
This statement is incorrect, as the hybrid closed-loop system does not eliminate the need for consistent treatment. Instead, it optimizes and automates the treatment process to make it more manageable for patients, but ongoing treatment and care are still essential for effective diabetes management.
D) results in fewer hospitalizations related to management of T1D.
While it is possible that improved management through the hybrid closed-loop system may lead to a reduction in hospitalizations, this is not a guaranteed consequence. The system primarily focuses on automating insulin delivery and monitoring, rather than directly addressing hospitalization rates.
Conclusion
The hybrid closed-loop system's primary advantage lies in its ability to automate blood glucose monitoring and insulin dosing, which significantly reduces the patient's need for constant input. This advancement allows individuals with type 1 diabetes to manage their condition more easily and effectively, setting it apart from the other options that either misrepresent its function or imply a lesser degree of ongoing care is necessary.